BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17218310)

  • 1. Toward molecular dissection of PrPC-PrPSc interactions.
    Solforosi L; Bellon A; Schaller M; Cruite JT; Abalos GC; Williamson RA
    J Biol Chem; 2007 Mar; 282(10):7465-71. PubMed ID: 17218310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying key components of the PrPC-PrPSc replicative interface.
    Abalos GC; Cruite JT; Bellon A; Hemmers S; Akagi J; Mastrianni JA; Williamson RA; Solforosi L
    J Biol Chem; 2008 Dec; 283(49):34021-8. PubMed ID: 18826953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc.
    Moroncini G; Kanu N; Solforosi L; Abalos G; Telling GC; Head M; Ironside J; Brockes JP; Burton DR; Williamson RA
    Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10404-9. PubMed ID: 15240877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prion protein self-peptides modulate prion interactions and conversion.
    Rigter A; Priem J; Timmers-Parohi D; Langeveld JP; van Zijderveld FG; Bossers A
    BMC Biochem; 2009 Nov; 10():29. PubMed ID: 19943977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying critical sites of PrP(c)-PrP(Sc) interaction in prion-infected cells by dominant-negative inhibition.
    Taguchi Y; Schätzl HM
    Prion; 2013; 7(6):452-6. PubMed ID: 24401595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping of possible prion protein self-interaction domains using peptide arrays.
    Rigter A; Langeveld JP; Timmers-Parohi D; Jacobs JG; Moonen PL; Bossers A
    BMC Biochem; 2007 Apr; 8():6. PubMed ID: 17430579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse prion protein (PrP) segment 100 to 104 regulates conversion of PrP(C) to PrP(Sc) in prion-infected neuroblastoma cells.
    Hara H; Okemoto-Nakamura Y; Shinkai-Ouchi F; Hanada K; Yamakawa Y; Hagiwara K
    J Virol; 2012 May; 86(10):5626-36. PubMed ID: 22398286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The charge structure of helix 1 in the prion protein regulates conversion to pathogenic PrPSc.
    Norstrom EM; Mastrianni JA
    J Virol; 2006 Sep; 80(17):8521-9. PubMed ID: 16912302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological mimicry of PrPC-PrPSc interactions: antibody-induced PrP misfolding.
    Li L; Guest W; Huang A; Plotkin SS; Cashman NR
    Protein Eng Des Sel; 2009 Aug; 22(8):523-9. PubMed ID: 19602568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular biology and pathology of prion strains in sporadic human prion diseases.
    Gambetti P; Cali I; Notari S; Kong Q; Zou WQ; Surewicz WK
    Acta Neuropathol; 2011 Jan; 121(1):79-90. PubMed ID: 21058033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different antigenicities of the N-terminal region of cellular and scrapie prion proteins.
    Ushiki-Kaku Y; Iwamaru Y; Masujin K; Imamura M; Itohara S; Ogawa-Goto K; Hattori S; Yokoyama T
    Microbiol Immunol; 2013 Nov; 57(11):792-6. PubMed ID: 24117858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA converts cellular prion protein into the beta-sheet conformation and inhibits prion peptide aggregation.
    Cordeiro Y; Machado F; Juliano L; Juliano MA; Brentani RR; Foguel D; Silva JL
    J Biol Chem; 2001 Dec; 276(52):49400-9. PubMed ID: 11604397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical significance of the region between Helix 1 and 2 for efficient dominant-negative inhibition by conversion-incompetent prion protein.
    Taguchi Y; Mistica AM; Kitamoto T; Schätzl HM
    PLoS Pathog; 2013; 9(6):e1003466. PubMed ID: 23825952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion efficiency of bank vole prion protein in vitro is determined by residues 155 and 170, but does not correlate with the high susceptibility of bank voles to sheep scrapie in vivo.
    Piening N; Nonno R; Di Bari M; Walter S; Windl O; Agrimi U; Kretzschmar HA; Bertsch U
    J Biol Chem; 2006 Apr; 281(14):9373-84. PubMed ID: 16455657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Live cell fluorescence resonance energy transfer predicts an altered molecular association of heterologous PrPSc with PrPC.
    Mallik S; Yang W; Norstrom EM; Mastrianni JA
    J Biol Chem; 2010 Mar; 285(12):8967-75. PubMed ID: 20086009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The AGAAAAGA palindrome in PrP is required to generate a productive PrPSc-PrPC complex that leads to prion propagation.
    Norstrom EM; Mastrianni JA
    J Biol Chem; 2005 Jul; 280(29):27236-43. PubMed ID: 15917252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of bovine T194A PrP(C) by PrP(Sc)-specific antibodies: potential implications for immunotherapy of familial prion diseases.
    Madampage CA; Määttänen P; Marciniuk K; Brownlie R; Andrievskaia O; Potter A; Cashman NR; Lee JS; Napper S
    Prion; 2013; 7(4):301-11. PubMed ID: 23787697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-PrP form of human prion protein stimulates production of monoclonal antibodies to epitope 91-110 that recognise native PrPSc.
    Khalili-Shirazi A; Kaisar M; Mallinson G; Jones S; Bhelt D; Fraser C; Clarke AR; Hawke SH; Jackson GS; Collinge J
    Biochim Biophys Acta; 2007 Nov; 1774(11):1438-50. PubMed ID: 17936697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping the prion protein using recombinant antibodies.
    Williamson RA; Peretz D; Pinilla C; Ball H; Bastidas RB; Rozenshteyn R; Houghten RA; Prusiner SB; Burton DR
    J Virol; 1998 Nov; 72(11):9413-8. PubMed ID: 9765500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservation of a glycine-rich region in the prion protein is required for uptake of prion infectivity.
    Harrison CF; Lawson VA; Coleman BM; Kim YS; Masters CL; Cappai R; Barnham KJ; Hill AF
    J Biol Chem; 2010 Jun; 285(26):20213-23. PubMed ID: 20356832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.